ArticleJTCVS open2025
Discharge prescription patterns in multiarterial versus single-arterial coronary artery bypass grafting: A regional multicenter cohort analysis.
Article in JTCVS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Medical management after multiarterial grafting (MAG) versus single arterial grafting (SAG) in coronary artery bypass grafting (CABG) is less characterized. We sought to identify discharge prescription patterns after CABG on the basis of conduit selection. Methods: This retrospective study included patients from a 17-institution regional collaborative undergoing isolated CABG from 2020 to 2023. Patients were stratified into MAG and SAG cohorts. Primary analysis included dual antiplatelet therapy (DAPT), anticoagulation, beta-blocker, and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker discharge prescription rates. Multivariable logistic regression was executed to assess independent associations. Results: The cohort included 10,966 patients (8904 SAG, 2062 MAG). Patients in the SAG group were significantly older with a median age of 67 years [61, 74] versus 61 years [55, 68] in the MAG cohort. Patients in the SAG group were more likely to present with non-ST-segment elevation myocardial infarction (34.1% vs 31.0%, Conclusions: Patients undergoing MAG are more likely to be prescribed DAPT at discharge, independent of clinical presentation and baseline comorbidities. Differences in postrevascularization medications between patients who receive MAG and SAG differ and should be considered when comparing groups and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.